Published online Dec 24, 2025. doi: 10.5306/wjco.v16.i12.111701
Revised: August 24, 2025
Accepted: November 14, 2025
Published online: December 24, 2025
Processing time: 169 Days and 10.5 Hours
Intrathyroidal thymic carcinoma (ITC) is a rare malignant epithelial tumour of thymic origin occurring within the thyroid. Histologically, it resembles thymic carcinoma, with squamous cell carcinoma being the most common subtype, and immunohistochemical staining typically exhibits features consistent with thymic neoplasms.
We report the case of a 68-year-old woman who presented with a left-sided neck mass of one year’s duration. And the neck lump had been gradually enlarging over the course of a year, reaching the size of a goose egg within six months. Thyroid ultrasound revealed a normally sized thyroid gland. A 3.9 cm × 3.4 cm × 2.7 cm hypoechoic lesion with irregular echogenicity was observed outside the capsule of the lower pole of the left lobe. The mass exhibited regular morphology, well-defined margins, and close adherence to the thyroid’s lower pole. Micro
Based on these findings, the patient was diagnosed as ITC with both squamous cell and small cell carcinoma components. To date, nearly 100 cases of ITC have been reported in the literature. However, no prior reports of ITC exhibiting both squamous cell and small cell carcinoma components. This case report provides information on the microscopic morphological features of ITC with both squamous cell and small cell carcinoma components, which can help pathologists to expands the understanding of the pathological spectrum of the disease.
Core Tip: Intrathyroidal thymic carcinoma (ITC) is a rare malignant epithelial tumour of thymic origin occurring within the thyroid. ITC with both squamous cell and small cell carcinoma components has not been reported to date. This case report provides information on the microscopic morphological features of ITC with both squamous cell and small cell carcinoma components, and new potential evidence for the origin of ITC. As cluster of differentiation 117+ immunophenotype is a critical clue that should prompt consideration of ITC, which requires a different diagnostic and therapeutic approach than metastatic small cell lung cancer.
